Healthcare
Privia Health Group, Inc.(PRVA)
Live Price
Offline$23.67
+1.11% today
1Y Change
+9.53%
Window
Jun 23, 2025 โ Jun 18, 2026
- Market Cap
- $3.12B
- Revenue Growth
- +22.3%
- EPS Growth
- +58.3%
- Dividend Yield
- 0.0%
Coverage: 249 bars ยท Jun 23, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Privia Health Group, Inc. (PRVA) is a Healthcare stock with a market cap of $3.12B and listed on NASDAQ. The stock last traded around $23.67 and up 9.5% across the available one-year price window (Jun 23, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +22.3%, EPS growth of +58.3%, a dividend yield of 0.0%. What stands out right now is revenue +22.3%, EPS +58.3%, free cash flow +55.6% with operating margin 1.6% and ROIC 2.9%. Valuation already assumes a fairly strong business story at P/E 133.6 and price/sales 1.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines PRVA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+22.3% vs +7.6% peer median
Operating Margin
Below sector median
+1.6% vs +19.4% peer median
P/E
Above sector median
133.6 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 14, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +22.3% and EPS at +58.3%, with operating margin around 1.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -2.6% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 14, 2026 | โ | -1.2% | -2.6% | +0.8% |
2026 Feb 26, 2026 | +75.0% | -4.7% | -4.3% | -19.0% |
2025 Nov 6, 2025 | -16.7% | -2.3% | -1.0% | -0.6% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PRVA
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
PRVA Max Drawdown
-24.17%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for PRVA and SPY.
Company Overview
Privia Health Group, Inc.
NASDAQ Global Select
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
- Leadership
- Parth Mehrotra
- IPO Date
- Apr 28, 2021
- Employees
- 1.1k
- Street Address
- 950 North Glebe Road
- Mailing
- Arlington, VA, 22203
- Region
- Arlington, VA, US
- Reporting Currency
- USD
- Investor Line
- 571 366 8850
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 133.6
- EV/EBITDA
- 54.3
- Price/Sales
- 1.5
- Price/Book
- 4.2
Growth
- Revenue
- +22.3%
- EPS
- +58.3%
- Free Cash Flow
- +55.6%
Profitability
- Gross Margin
- 9.6%
- Operating Margin
- 1.6%
- Net Margin
- 1.1%
- ROE
- 3.3%
- ROIC
- 2.9%
Balance Sheet
- Debt/Equity
- 0.01
- Current Ratio
- 1.60
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.